Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2019

01-03-2019 | Tuberculosis | Images in Hematology

Tuberculous lymphadenitis mimicking Castleman disease-like histological features

Authors: Makoto Ide, Tomoko Yokoyama, Tetsuro Ogino

Published in: International Journal of Hematology | Issue 3/2019

Login to get access

Excerpt

Multicentric Castleman disease (MCD) is an indolent lymphoproliferative disorder of unknown etiology. Due to the absence of specific histological features in Castleman disease, diagnostic criteria also require the exclusion of other diseases. We herein present a distinctive case of tuberculosis lymphadenitis mimicking Castleman disease-like histological features. …
Metadata
Title
Tuberculous lymphadenitis mimicking Castleman disease-like histological features
Authors
Makoto Ide
Tomoko Yokoyama
Tetsuro Ogino
Publication date
01-03-2019
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2019
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-02579-6

Other articles of this Issue 3/2019

International Journal of Hematology 3/2019 Go to the issue

Case Report

Relationship between clinical course of nivolumab-related myositis and immune status in a patient with Hodgkin’s lymphoma after allogeneic hematopoietic stem cell transplantation

Original Article

Association of high levels of plasma OX40 with acute adult T-cell leukemia

Original Article

Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan

Case Report

Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin

Correction

Correction to: Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia

Images in Hematology

A case of pancytopenia and hypercellular bone marrow: when family history can suggest the diagnosis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits